A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.

@article{Kinon2006A2R,
  title={A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.},
  author={Bruce J. Kinon and Ilya Lipkovich and Sara B Edwards and David H Adams and Haya Ascher-Svanum and Samuel G. Siris},
  journal={Journal of clinical psychopharmacology},
  year={2006},
  volume={26 2},
  pages={157-62}
}
OBJECTIVE The objective of this study is to compare olanzapine with ziprasidone therapy in patients with schizophrenia or schizoaffective disorder and experiencing depressive symptoms. METHODS This randomized, double-blind, 24-week, fixed-dose study compared olanzapine (n = 202) and ziprasidone (n = 192) for patients with schizophrenia or schizoaffective… CONTINUE READING